Use of Intravaginal Cooling to Provide Symptom Relief in Women With Vulvovaginal Candidiasis and Reduce Immunopathology in an Accompanying Mouse Model
The Journal of Infectious Diseases · 2025
DOI: 10.1093/infdis/jiaf028 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von Junko Yano und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Craniofacial Biology, School of Dentistry, LSU Health, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Candidiasis, Vulvovaginal, Candida albicans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Coologics, LSU Health Foundation.
Abstract (Originalsprache)
Background
Vulvovaginal candidiasis (VVC), caused primarily by Candida albicans, is treated with anti-fungal drugs, often with variable efficacy and relapses. New therapeutic strategies, including drug-free alternatives, are needed. Upon overgrowth or environmental triggers, C. albicans commensal yeast transitions into hyphae resulting in an aberrant immunopathologic neutrophil response that contributes to the characteristic signs and symptoms of vaginitis. The purpose of this study was to evaluate the efficacy of an intravaginal cooling device (Vlisse) in women with VVC to provide symptom relief via putative reversal of C. albicans hyphae to yeast, with additional proof of principle in an animal model.
Methods
Five women with VVC were instructed to use the device twice daily for 3 days. Vulvovaginal symptoms were monitored and scored for each use, followed by pelvic examination at 30 days. A mouse model of VVC employed cooled micro stir rods to evaluate the cooling effect on fungal morphology and vaginal immunopathology.
Results
Clinical cure was achieved in all women. In the mouse model, the insertion of pre-cooled magnetic rods intravaginally for short periods over 3 days, reduced the immunopathogenic neutrophil infiltration and hyphae.
Conclusions
Intravaginal cooling provides clinical cure for VVC and proof of principle in an animal model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Craniofacial Biology, School of Dentistry, LSU Health, New Orleans, Louisiana, USA.
- Coologics, Inc., Cleveland, Ohio, USA.
- Physicians Care Clinical Research Center, Sarasota Memorial Hospital, Sarasota, Florida, USA.
ORCID-Profile: Junko Yano, Kimberly Langdon, Mairi C Noverr, Paul L Fidel
Förderung
- NIGMS NIH HHS
- Coologics
- LSU Health Foundation
- National Institute of General Medical Sciences, National Institute of Health
Zitieren
APA
Yano, J., Langdon, K., Swor, M., Noverr, M. C., & Fidel, P. L. (2025). Use of Intravaginal Cooling to Provide Symptom Relief in Women With Vulvovaginal Candidiasis and Reduce Immunopathology in an Accompanying Mouse Model. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf028
Vancouver
Yano J, Langdon K, Swor M, Noverr MC, Fidel PL. Use of Intravaginal Cooling to Provide Symptom Relief in Women With Vulvovaginal Candidiasis and Reduce Immunopathology in an Accompanying Mouse Model. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf028
BibTeX
@article{Yano2025,
author = {Yano, Junko and Langdon, Kimberly and Swor, Michael and Noverr, Mairi C and Fidel, Paul L},
title = {Use of Intravaginal Cooling to Provide Symptom Relief in Women With Vulvovaginal Candidiasis and Reduce Immunopathology in an Accompanying Mouse Model},
journal = {The Journal of Infectious Diseases},
year = {2025},
doi = {10.1093/infdis/jiaf028}
}
EUVIMED